This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Sweta Killa
Sector ETF report for PSCH
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Trump's Presidential 2 Years: Must-See ETF Areas
by Sanghamitra Saha
Inside the ETF areas that were most talked-about in the Trump presidency.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Healthcare ETFs to Buy Ahead of Q3 Earnings
by Sweta Killa
The positive estimate revisions suggest continued outperformance for the healthcare ETFs.
Top-Ranked Healthcare ETFs for Long-Term Investors
by Neena Mishra
Healthcare is now the best-performing sector of 2018. We highlight two top-ranked ETFs suitable for long-term investors.
3 Globally Winning ETF Areas of Q3
by Sanghamitra Saha
Inside the winning ETF areas of the third quarter.
Top Performing ETFs of the Third Quarter
by Neena Mishra
Healthcare emerged as the new leader in Q3. Here is what investors need to know about best performing sectors and ETFs.
Q3 ETF Asset Flow Roundup: What's Hot & What's Not
by Sweta Killa
We have highlighted several zones and their ETFs that have garnered enough investors' interest while few that have shunned by investors.
Fed Hikes Rates as Expected: ETF Areas That Gained
by Sanghamitra Saha
The Fed hikes rates as expected and there was no wild movement in the market. These ETF areas ended in the green post hike.
5 Health Care ETFs Outperforming XLV on YTD Basis
by Zacks Equity Research
Health care ETFs provide handsome returns year to date.
4 Sector ETFs Brimming With Inflows
by Sanghamitra Saha
If some sector ETFs attracted investors' attention past months, those were all defensive.
Health Care ETFs Outperforming: Will the Rally Last?
by Sanghamitra Saha
Health care ETFs are defensive ones, which helped those to shine amid market doldrums.
ETF Asset Report of July
by Sanghamitra Saha
Inside the ETFs what amassed solid assets and the ones that lost the most.
Healthcare ETFs to Buy on Solid Q2 Earnings Expectations
by Sweta Killa
With earnings surprises well in the cards, the healthcare sector is expected to witness earnings growth of 9.1% in the second quarter, suggesting continued outperformance for healthcare ETFs.
Healthcare ETFs to Ride on UnitedHealth's Solid Q2 & Outlook
by Sweta Killa
Investors should tap the opportunity with ETFs having the largest allocation to UnitedHealth.
Healthcare ETFs in Focus Following JNJ Q2 Results
by Sweta Killa
Investors should closely watch the movement of the Johnson & Johnson and keep a close eye on ETFs having double-digit allocation to this diversified drug maker.
5 ETFs to Play in July
by Sanghamitra Saha
Investors may tap these five ETFs for gains as President Trump aims the first shot in the trade war.
Want to Tap Merger Mania? Play Top-Ranked Health Care ETFs
by Sanghamitra Saha
What is driving Healthcare merger-mania and how to tap it with ETFs.
5 ETF Ways to Trade 6-Year High U.S. Inflation
by Sanghamitra Saha
Why these ETF areas can gain in an inflationary environment.
Play the Best Sector of Summer With These ETFs & Stocks
by Sanghamitra Saha
Health care is apparently one of the best-performing sectors of summer. So, track these ETFs and stocks.
Should You Invest in the PowerShares S&P SmallCap Health Care Portfolio (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Don't Sell in May and Go Away: Follow These ETF Strategies
by Sweta Killa
Investors could follow some ideas that could lead to a winning portfolio during this soft six-month period.
Healthcare ETFs in Focus After Johnson & Johnson Q1 Earnings
by Zacks Equity Research
Johnson & Johnson reports Q1 results with both revenues and EPS beating estimates.